These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32127638)

  • 21. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
    Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
    Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of diffuse large cell lymphoma from follicular lymphoma with multiple immunoglobulin heavy chain gene rearrangement occurring in a patient with Wiskott-Aldrich syndrome.
    Kawakami K; Yamaguchi M; Watanabe Y; Murata T
    Int J Hematol; 2002 Aug; 76(2):196-8. PubMed ID: 12215021
    [No Abstract]   [Full Text] [Related]  

  • 24. Luigi Naldini on His Lifelong Involvement with the Development of Gene Therapy.
    Wilson JM
    Hum Gene Ther Clin Dev; 2016 Sep; 27(3):83-6. PubMed ID: 27556334
    [No Abstract]   [Full Text] [Related]  

  • 25. Extramedullary early T-cell precursor acute lymphoblastic lymphoma presenting as blast crisis of CML.
    Wang HY; Tzachanis D
    Blood; 2020 Aug; 136(9):1112. PubMed ID: 32853380
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation.
    Brigida I; Scaramuzza S; Lazarevic D; Cittaro D; Ferrua F; Leonardelli L; Alessio M; Forma O; Lanzani C; Viarengo G; Ciceri F; Jankovic M; Pesce F; Aiuti A; Cicalese MP
    J Allergy Clin Immunol; 2016 Aug; 138(2):619-622.e7. PubMed ID: 27113846
    [No Abstract]   [Full Text] [Related]  

  • 27. Lessons from the Wiskott-Aldrich syndrome.
    Puck JM; Candotti F
    N Engl J Med; 2006 Oct; 355(17):1759-61. PubMed ID: 17065636
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene therapy goes the distance in Wiskott-Aldrich syndrome.
    Biffi A
    Nat Med; 2022 Jan; 28(1):24-25. PubMed ID: 35075290
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic impact of the absence of biallelic deletion at the
    Farah N; Kirkwood AA; Rahman S; Leon T; Jenkinson S; Gale RE; Patrick K; Hancock J; Samarasinghe S; Linch DC; Moorman AV; Goulden N; Vora A; Mansour MR
    Haematologica; 2018 Jul; 103(7):e288-e292. PubMed ID: 29519867
    [No Abstract]   [Full Text] [Related]  

  • 30. PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia.
    Jiang G; Zhang M; Yue B; Yang M; Carter C; Al-Quran SZ; Li B; Li Y
    Leuk Res; 2012 Nov; 36(11):1347-53. PubMed ID: 22898210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral vectors for the treatment of Wiskott-Aldrich syndrome.
    Nienhuis AW
    Gene Ther; 2005 Apr; 12(7):555-6. PubMed ID: 18360950
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How I manage patients with Wiskott Aldrich syndrome.
    Rivers E; Worth A; Thrasher AJ; Burns SO
    Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.
    Astrakhan A; Sather BD; Ryu BY; Khim S; Singh S; Humblet-Baron S; Ochs HD; Miao CH; Rawlings DJ
    Blood; 2012 May; 119(19):4395-407. PubMed ID: 22431569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.
    Dupré L; Trifari S; Follenzi A; Marangoni F; Lain de Lera T; Bernad A; Martino S; Tsuchiya S; Bordignon C; Naldini L; Aiuti A; Roncarolo MG
    Mol Ther; 2004 Nov; 10(5):903-15. PubMed ID: 15509508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.
    Strom TS; Turner SJ; Andreansky S; Liu H; Doherty PC; Srivastava DK; Cunningham JM; Nienhuis AW
    Blood; 2003 Nov; 102(9):3108-16. PubMed ID: 12855574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
    Barba P; Morgades M; Montesinos P; Gil C; Fox ML; Ciudad J; Moreno MJ; González-Campos J; Genescà E; Martínez-Carballeira D; Martino R; Vives S; Guardia R; Mercadal S; Artola MT; Cladera A; Tormo M; Esteve J; Bergua J; Vall-Llovera F; Ribera J; Martínez-Sanchez P; Amigo ML; Bermúdez A; Calbacho M; Hernández-Rivas JM; Feliu E; Orfao A; Ribera JM
    Eur J Haematol; 2019 Jan; 102(1):79-86. PubMed ID: 30267597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
    Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
    Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.